Baskhanbio Pharma Inc. (XKON:354390)
South Korea · Delayed Price · Currency is KRW 3,695.00
+190.00 (5.42%)
At close: Jun 18, 2026
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 24.56 billion as of June 18, 2026. Its market cap has decreased by -10.14% in one year.
Market Cap
24.56B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3,695.00
Market Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 24.56B, a decrease of -70.34%. That is a compound annual growth rate of -26.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 24.56B | -26.78% |
| Dec 30, 2025 | 33.55B | 11.42% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
| Jul 20, 2022 | 82.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korean Drug | 36.99B |
| HLscience | 29.84B |
| Kyung Nam Pharm | 28.91B |
| Pharmsville | 27.05B |
| Seoul Pharma | 24.31B |
| Daesung Microbiological Labs. | 24.28B |
| Hurum | 22.21B |
| BIFIDO | 20.53B |